Comparing Oral Lumbrokinase DLBS1033 and Betahistine Mesylate in Benign Paroxysmal Positional Vertigo

NCT07075289 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Benign Paroxysmal Positional Vertigo (Disorder)

Interventions

DRUG: DLBS1033
DRUG: Betahistine Mesylate tablet

Sponsor

Universitas Sebelas Maret

Collaborators

[object Object]